Cargando…
Vamorolone, a dissociative steroidal compound, reduces pro-inflammatory cytokine expression in glioma cells and increases activity and survival in a murine model of cortical tumor
Corticosteroids, such as dexamethasone, are routinely used as palliative care in neuro-oncology for their anti-inflammatory benefits, however many patients experience dose limiting side effects caused by glucocorticoid response element (GRE)-mediated transcription. The purpose of this study was to u...
Autores principales: | Wells, Elizabeth, Kambhampati, Madhuri, Damsker, Jesse M, Gordish-Dressman, Heather, Yadavilli, Sridevi, Becher, Oren J, Gittens, Jamila, Stampar, Mojca, Packer, Roger J, Nazarian, Javad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354737/ https://www.ncbi.nlm.nih.gov/pubmed/28030841 http://dx.doi.org/10.18632/oncotarget.14070 |
Ejemplares similares
-
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
por: Hoffman, Eric P., et al.
Publicado: (2018) -
Differential Expression of Wilms’ Tumor Protein in Diffuse Intrinsic Pontine Glioma
por: Lee, Sulgi, et al.
Publicado: (2019) -
The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice
por: Almeida, Luis E. F., et al.
Publicado: (2018) -
Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone
por: Fiorillo, Alyson A., et al.
Publicado: (2018) -
Pan-cancer atlas of somatic core and linker histone mutations
por: Bonner, Erin R., et al.
Publicado: (2023)